Commentary on the Homburg Lung: Pro/Con of Miniaturized ECCO2R.

B. Whitson,B. Shukrallah

DOI: https://doi.org/10.1097/MAT.0000000000000648

2017-09-01

Abstract:In the ASAIO Journal this year, Dr. Seiler et al.1 from Saarland University Medical Center, Homburg, Germany, present their series of patients from more than a 2-year period that underwent extracorporeal carbon dioxide removal (ECCO2R) via a miniaturized veno-venous blood circuit. Their findings are exciting for the advancement of the field and yield many points of discussion, in support and question. Extracorporeal life support (ECLS) has been evolving since the late 1970s2 and has gone from bulky, somewhat dangerous diffusion oxygenators and roller pumps to our current state of centrifugal blood pumps and hollow fiber, polymethylpentene oxygenators. The smaller profile pumps with a more favorable impact on the erythrocyte and the coagulation system have enabled further expansion. As the technology continues to improve, and the adverse events lessen, the role of ECLS will continue to expand and further enhance our patients’ lives.3 Seiler et al.1 use a single-site veno-venous ECCO2R circuit via a right internal jugular vein approach. This single site approach4,5 has benefits of improved ambulation and has shown promise in the setting of hypercapnic respiratory failure.5